Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging

BACKGROUND: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by two major and interconnected hallmarks: inflammation and progressive neurodegeneration. OBJECTIVE: The aim of this work was to compare neurodegenerative processes, in the form of global...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolind, Shannon, Gaetano, Laura, Assemlal, Haz-Edine, Bernasconi, Corrado, Bonati, Ulrike, Elliott, Colm, Hagenbuch, Niels, Magon, Stefano, Arnold, Douglas L, Traboulsee, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176619/
https://www.ncbi.nlm.nih.gov/pubmed/37148240
http://dx.doi.org/10.1177/13524585231162586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176619/
https://www.ncbi.nlm.nih.gov/pubmed/37148240
http://dx.doi.org/10.1177/13524585231162586

Ejemplares similares